K. Zaman

Bangladesh, icddr,b

K. Zaman, MBBS, PhD, MPH, is senior scientist and epidemiologist at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b).

For the last 33 years, Dr. Zaman has worked extensively in the design, implementation and analysis of data from clinical and community-based epidemiological/vaccine studies. His research primarily focuses on vaccines and infectious diseases. He has been involved with clinical studies on ORS, drug trial, vaccine studies, vitamin A supplementation and hospital surveillance. Dr. Zaman also has experience in community-based research on diarrheal and respiratory diseases, as well as other public health problems in Bangladesh.

Currently he is the Principal Investigator leading several rotavirus, influenza, pneumococcal, Hepatitis E, polio and Japanese encephalitis (JE) vaccine studies as well as epidemiological studies on tuberculosis in icddr,b. The vaccine studies included all of phases I, II, III, IV and with International Conference on Harmonisation Good Clinical Practice maintained.

Dr. Zaman obtained his MBBS in Bangladesh; he obtained his MPH and PhD from the Johns Hopkins University in infectious disease control. He has 145 publications in international journals and more than 120 presentations in scientific conferences. Dr. Zaman also serves as Section Editor of the Journal of “Health, Population and Nutrition” and is a reviewer for more than 20 international journals.


The ROTA Council was created in collaboration with an advisory group of 24 child health leaders from around the world. We promote the use of rotavirus vaccines as part of a comprehensive approach to addressing diarrheal disease.

logo-ivac logo-jhu
  • Stay up to date with the Rotavirus Organization of Technical Allies (ROTA)
    Sign up for the latest updates on rotavirus immunization-related science, policy, and access from the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.
  • This field is for validation purposes and should be left unchanged.
Subscribe to our newsletter